Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$25.07
1.074.46%
At close: -
$25.13
0.060.24%
After Hours: 7:04 PM EDT
Comments
Loading...
Astrana Health Analyst Ratings and Price Targets | NASDAQ:ASTH | Benzinga
Astrana Health Inc has a consensus price target of $53.29 based on the ratings of 8 analysts. The high is $70 issued by BTIG on October 3, 2024. The low is $36 issued by Barclays on April 1, 2025. The 3 most-recent analyst ratings were released by Barclays, Truist Securities, and B of A Securities on April 1, 2025, March 18, 2025, and March 4, 2025, respectively. With an average price target of $43.67 between Barclays, Truist Securities, and B of A Securities, there's an implied 73.76% upside for Astrana Health Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Truist Securities
B of A Securities
Baird
Stifel
1calculated from analyst ratings
Analyst Ratings for Astrana Health
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/01/2025 | Buy Now | 43.26% | Barclays | Andrew Mok56% | → $36 | Initiates | → Equal-Weight | Get Alert |
| 03/18/2025 | Buy Now | 83.05% | Truist Securities | Jailendra Singh37% | $50 → $46 | Maintains | Buy | Get Alert |
| 03/04/2025 | Buy Now | 94.99% | B of A Securities | Adam Ron46% | $55 → $49 | Maintains | Buy | Get Alert |
| 03/03/2025 | Buy Now | 98.97% | Baird | Michael Ha38% | $86 → $50 | Maintains | Outperform | Get Alert |
| 02/20/2025 | Buy Now | 122.84% | Stifel | Craig Jones46% | $70 → $56 | Maintains | Buy | Get Alert |
| 01/13/2025 | Buy Now | 98.97% | Truist Securities | Jailendra Singh37% | $59 → $50 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | 242.22% | Baird | Michael Ha38% | $67 → $86 | Maintains | Outperform | Get Alert |
| 11/08/2024 | Buy Now | 178.55% | Stifel | Craig Jones46% | $60 → $70 | Maintains | Buy | Get Alert |
| 10/14/2024 | Buy Now | 162.63% | TD Cowen | Ryan Langston26% | → $66 | Initiates | → Buy | Get Alert |
| 10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor66% | — | Initiates | → Sector Weight | Get Alert |
| 10/03/2024 | Buy Now | 178.55% | BTIG | David Larsen47% | $60 → $70 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | 166.61% | Baird | Michael Ha38% | $54 → $67 | Maintains | Outperform | Get Alert |
| 08/09/2024 | Buy Now | 134.78% | Truist Securities | Jailendra Singh37% | $50 → $59 | Maintains | Buy | Get Alert |
| 08/01/2024 | Buy Now | 138.76% | Stifel | Craig Jones46% | $48 → $60 | Maintains | Buy | Get Alert |
| 07/11/2024 | Buy Now | 98.97% | Truist Securities | Jailendra Singh37% | $44 → $50 | Upgrade | Hold → Buy | Get Alert |
| 06/27/2024 | Buy Now | 91.01% | Stifel | Craig Jones46% | $45 → $48 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | 114.88% | Baird | Michael Ha38% | → $54 | Initiates | → Outperform | Get Alert |
| 05/08/2024 | Buy Now | 79.07% | Stifel | Craig Jones46% | $50 → $45 | Maintains | Buy | Get Alert |
| 03/01/2024 | Buy Now | 75.09% | Truist Securities | Jailendra Singh37% | $41 → $44 | Maintains | Hold | Get Alert |
FAQ
What is the target price for Astrana Health (ASTH) stock?
The latest price target for Astrana Health (NASDAQ:ASTH) was reported by Barclays on April 1, 2025. The analyst firm set a price target for $36.00 expecting ASTH to rise to within 12 months (a possible 43.26% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Astrana Health (ASTH)?
The latest analyst rating for Astrana Health (NASDAQ:ASTH) was provided by Barclays, and Astrana Health initiated their equal-weight rating.
When was the last upgrade for Astrana Health (ASTH)?
The last upgrade for Astrana Health Inc happened on July 11, 2024 when Truist Securities raised their price target to $50. Truist Securities previously had a hold for Astrana Health Inc.
When was the last downgrade for Astrana Health (ASTH)?
There is no last downgrade for Astrana Health.
When is the next analyst rating going to be posted or updated for Astrana Health (ASTH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Astrana Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Astrana Health was filed on April 1, 2025 so you should expect the next rating to be made available sometime around April 1, 2026.
Is the Analyst Rating Astrana Health (ASTH) correct?
While ratings are subjective and will change, the latest Astrana Health (ASTH) rating was a initiated with a price target of $0.00 to $36.00. The current price Astrana Health (ASTH) is trading at is $25.13, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
